<?xml version="1.0" encoding="UTF-8"?>
<p id="para0006">Three prominent immune dysregulation syndromes that may arise after cellular therapy and stem cell transplantation include CRS, sHLH and IRIS. All three have clinical and laboratory characteristics in common and with patterns described in patients with severe COVID-19 (
 <xref rid="tbl0001" ref-type="table">Table 1</xref> ). These immune responses may be fatal if not recognized and treated promptly.
</p>
